Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bilirubin | 23 | 2020 | 438 | 4.100 |
Why?
|
| Hepatitis | 3 | 2023 | 227 | 1.570 |
Why?
|
| Esophageal and Gastric Varices | 3 | 2022 | 215 | 1.440 |
Why?
|
| Hyperbilirubinemia | 3 | 2020 | 74 | 1.150 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2017 | 693 | 1.080 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2015 | 514 | 0.940 |
Why?
|
| Liver Cirrhosis | 6 | 2024 | 1960 | 0.880 |
Why?
|
| HIV Protease Inhibitors | 2 | 2020 | 430 | 0.760 |
Why?
|
| Nail Diseases | 1 | 2021 | 54 | 0.750 |
Why?
|
| Nails | 1 | 2021 | 298 | 0.670 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2022 | 1096 | 0.590 |
Why?
|
| Lipid Bilayers | 5 | 2001 | 379 | 0.580 |
Why?
|
| Hepacivirus | 3 | 2018 | 1344 | 0.570 |
Why?
|
| Cell Movement | 3 | 2017 | 5210 | 0.480 |
Why?
|
| Receptors, LDL | 1 | 2017 | 493 | 0.460 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 1126 | 0.430 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2017 | 1134 | 0.430 |
Why?
|
| Conflict of Interest | 1 | 2018 | 556 | 0.420 |
Why?
|
| Liver Diseases | 3 | 2024 | 1305 | 0.390 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 588 | 0.380 |
Why?
|
| Liver | 13 | 2023 | 7577 | 0.380 |
Why?
|
| Antioxidants | 2 | 2017 | 1673 | 0.350 |
Why?
|
| Taurocholic Acid | 1 | 2010 | 44 | 0.350 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2002 | 96 | 0.350 |
Why?
|
| Hepatitis B, Chronic | 2 | 2006 | 413 | 0.340 |
Why?
|
| Genes, APC | 1 | 2010 | 145 | 0.330 |
Why?
|
| Up-Regulation | 2 | 2015 | 4146 | 0.330 |
Why?
|
| Monocytes | 1 | 2017 | 2605 | 0.290 |
Why?
|
| Intestinal Neoplasms | 1 | 2010 | 314 | 0.280 |
Why?
|
| Giant Cells | 1 | 2008 | 187 | 0.280 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2149 | 0.280 |
Why?
|
| Ammonia | 2 | 2007 | 247 | 0.280 |
Why?
|
| Colitis | 1 | 2015 | 1242 | 0.270 |
Why?
|
| Carnitine | 1 | 2007 | 253 | 0.270 |
Why?
|
| Serum Albumin | 3 | 2000 | 677 | 0.260 |
Why?
|
| Hepatitis C | 3 | 2018 | 1595 | 0.260 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2008 | 173 | 0.250 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1551 | 0.250 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 859 | 0.250 |
Why?
|
| Lamivudine | 2 | 2006 | 367 | 0.240 |
Why?
|
| Methylprednisolone | 2 | 2021 | 386 | 0.240 |
Why?
|
| Intracellular Membranes | 3 | 2002 | 388 | 0.240 |
Why?
|
| Fatty Acids | 3 | 2007 | 1812 | 0.230 |
Why?
|
| Phosphatidylcholines | 5 | 2001 | 406 | 0.210 |
Why?
|
| Leukocytes | 2 | 2015 | 2035 | 0.210 |
Why?
|
| Rats, Gunn | 3 | 2010 | 11 | 0.210 |
Why?
|
| Alanine Transaminase | 2 | 2024 | 606 | 0.200 |
Why?
|
| Circoviridae | 1 | 2001 | 3 | 0.200 |
Why?
|
| Hepatitis Viruses | 1 | 2001 | 15 | 0.200 |
Why?
|
| Circoviridae Infections | 1 | 2001 | 5 | 0.200 |
Why?
|
| Endotoxins | 1 | 2004 | 519 | 0.190 |
Why?
|
| Indinavir | 1 | 2001 | 73 | 0.190 |
Why?
|
| Adenoma | 2 | 2010 | 2159 | 0.190 |
Why?
|
| Fluorescence | 2 | 2001 | 756 | 0.190 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2021 | 361 | 0.190 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1090 | 0.190 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 911 | 0.190 |
Why?
|
| Malnutrition | 1 | 2007 | 632 | 0.180 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2001 | 141 | 0.180 |
Why?
|
| Stearic Acids | 1 | 2001 | 56 | 0.180 |
Why?
|
| Paracentesis | 1 | 2001 | 99 | 0.170 |
Why?
|
| Hepatitis B Vaccines | 1 | 2001 | 178 | 0.170 |
Why?
|
| Phospholipids | 2 | 2001 | 787 | 0.170 |
Why?
|
| Insulin Resistance | 2 | 2024 | 3986 | 0.160 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2002 | 620 | 0.160 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 3603 | 0.160 |
Why?
|
| Rats | 12 | 2010 | 23760 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 15662 | 0.160 |
Why?
|
| Ascites | 1 | 2001 | 338 | 0.160 |
Why?
|
| Brain Diseases | 1 | 2007 | 1554 | 0.150 |
Why?
|
| Apolipoproteins | 1 | 2000 | 328 | 0.150 |
Why?
|
| Biological Transport | 6 | 2002 | 2085 | 0.150 |
Why?
|
| Kinetics | 8 | 2002 | 6329 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 398 | 0.150 |
Why?
|
| Cholesterol | 4 | 2018 | 2914 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 684 | 0.140 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 1904 | 0.140 |
Why?
|
| Neoplasms | 3 | 2024 | 22371 | 0.140 |
Why?
|
| Bile Acids and Salts | 2 | 1996 | 398 | 0.140 |
Why?
|
| Glutathione Transferase | 2 | 1996 | 564 | 0.140 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 611 | 0.130 |
Why?
|
| Humans | 41 | 2024 | 768166 | 0.130 |
Why?
|
| Colorectal Neoplasms | 2 | 2006 | 6974 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2004 | 2146 | 0.120 |
Why?
|
| Antiviral Agents | 2 | 2018 | 3073 | 0.120 |
Why?
|
| Collagenases | 1 | 1995 | 221 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 154 | 0.120 |
Why?
|
| Interleukin-5 | 1 | 2015 | 267 | 0.120 |
Why?
|
| HIV Infections | 2 | 2020 | 17569 | 0.120 |
Why?
|
| Animals | 21 | 2017 | 169246 | 0.120 |
Why?
|
| Diffusion | 3 | 2002 | 815 | 0.120 |
Why?
|
| Dextran Sulfate | 1 | 2015 | 258 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 150 | 0.120 |
Why?
|
| Biopsy | 2 | 2021 | 6793 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2001 | 1354 | 0.110 |
Why?
|
| Nitrates | 1 | 2015 | 260 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2004 | 8128 | 0.110 |
Why?
|
| Retrospective Studies | 8 | 2024 | 81762 | 0.110 |
Why?
|
| Biological Transport, Active | 3 | 2001 | 323 | 0.110 |
Why?
|
| Carrier Proteins | 3 | 2002 | 4937 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 1065 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 2219 | 0.110 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 221 | 0.100 |
Why?
|
| Apoptosis | 2 | 2010 | 9523 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 1298 | 0.100 |
Why?
|
| Bone Density | 1 | 2006 | 3573 | 0.100 |
Why?
|
| Male | 22 | 2024 | 364719 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2541 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 596 | 0.100 |
Why?
|
| Cesarean Section | 1 | 2001 | 1425 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2001 | 2486 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.090 |
Why?
|
| Middle Aged | 14 | 2024 | 223492 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3814 | 0.090 |
Why?
|
| Mitochondria | 1 | 2004 | 3681 | 0.090 |
Why?
|
| Cell Line | 3 | 2015 | 15597 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2001 | 2333 | 0.090 |
Why?
|
| Models, Biological | 4 | 2002 | 9495 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2017 | 2614 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 10760 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 1995 | 536 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2002 | 3467 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6526 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 2 | 2001 | 320 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 2973 | 0.080 |
Why?
|
| Liposomes | 3 | 2001 | 790 | 0.080 |
Why?
|
| Solubility | 2 | 2002 | 1083 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2002 | 293 | 0.080 |
Why?
|
| Mice | 5 | 2017 | 82029 | 0.080 |
Why?
|
| Aorta | 1 | 2017 | 2045 | 0.080 |
Why?
|
| Female | 16 | 2024 | 397192 | 0.080 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 3044 | 0.080 |
Why?
|
| Vaccination | 1 | 2001 | 3437 | 0.080 |
Why?
|
| Collagen | 1 | 2017 | 2643 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4755 | 0.080 |
Why?
|
| Cell Membrane | 5 | 2000 | 3655 | 0.080 |
Why?
|
| Prevalence | 2 | 2021 | 15869 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 4413 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 22379 | 0.070 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2007 | 20 | 0.070 |
Why?
|
| Glycoproteins | 1 | 1995 | 2202 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 957 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1801 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6395 | 0.070 |
Why?
|
| Azathioprine | 1 | 2008 | 354 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2001 | 694 | 0.070 |
Why?
|
| Fibrosis | 2 | 2024 | 2080 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2001 | 3250 | 0.060 |
Why?
|
| Proteins | 1 | 2001 | 6009 | 0.060 |
Why?
|
| Logistic Models | 1 | 2020 | 13290 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2017 | 23645 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2018 | 2401 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2018 | 3968 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12543 | 0.060 |
Why?
|
| Hepatitis B e Antigens | 1 | 2006 | 135 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2004 | 6124 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2006 | 275 | 0.060 |
Why?
|
| Microsomes, Liver | 2 | 1996 | 174 | 0.060 |
Why?
|
| Jaundice | 1 | 2005 | 95 | 0.060 |
Why?
|
| beta Catenin | 1 | 2010 | 1047 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2004 | 103 | 0.060 |
Why?
|
| Carrageenan | 1 | 2004 | 71 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2004 | 173 | 0.060 |
Why?
|
| Particle Size | 2 | 2001 | 1649 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2004 | 165 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 4362 | 0.060 |
Why?
|
| Hospitalization | 1 | 2024 | 10840 | 0.060 |
Why?
|
| Cytoprotection | 1 | 2004 | 200 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 319 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2005 | 677 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2004 | 173 | 0.050 |
Why?
|
| Prednisone | 1 | 2008 | 1567 | 0.050 |
Why?
|
| Endotoxemia | 1 | 2004 | 198 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39348 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2023 | 54926 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2004 | 730 | 0.050 |
Why?
|
| Hepatitis B virus | 1 | 2006 | 533 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 40218 | 0.050 |
Why?
|
| Hindlimb | 1 | 2004 | 516 | 0.050 |
Why?
|
| Weight Loss | 2 | 2024 | 2721 | 0.050 |
Why?
|
| Potassium Iodide | 1 | 2001 | 13 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2004 | 364 | 0.050 |
Why?
|
| Cattle | 2 | 2000 | 3819 | 0.050 |
Why?
|
| Thermodynamics | 2 | 1995 | 591 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2010 | 4030 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5706 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2001 | 153 | 0.050 |
Why?
|
| Energy Transfer | 1 | 2001 | 109 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14488 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 882 | 0.050 |
Why?
|
| Chemical Phenomena | 1 | 2001 | 486 | 0.050 |
Why?
|
| Ligands | 2 | 2001 | 3284 | 0.050 |
Why?
|
| Aged | 8 | 2024 | 171504 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2001 | 136 | 0.050 |
Why?
|
| Apolipoproteins D | 1 | 2000 | 14 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2000 | 30 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 1981 | 157 | 0.040 |
Why?
|
| Pancreatitis | 1 | 2007 | 1087 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2005 | 556 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13676 | 0.040 |
Why?
|
| Mathematics | 1 | 2001 | 704 | 0.040 |
Why?
|
| Cytokines | 1 | 2015 | 7453 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2021 | 526 | 0.040 |
Why?
|
| Adenine | 1 | 2006 | 995 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 1981 | 201 | 0.040 |
Why?
|
| Spin Labels | 1 | 2001 | 336 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 12252 | 0.040 |
Why?
|
| Eating | 1 | 2006 | 1542 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 11519 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2004 | 2278 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2007 | 824 | 0.040 |
Why?
|
| Carbon Radioisotopes | 1 | 2000 | 567 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2001 | 611 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3590 | 0.040 |
Why?
|
| Patient Simulation | 1 | 2001 | 297 | 0.040 |
Why?
|
| Erythrocyte Membrane | 1 | 2000 | 438 | 0.040 |
Why?
|
| Adult | 9 | 2022 | 223646 | 0.040 |
Why?
|
| Fasting | 1 | 2004 | 1610 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2008 | 2167 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1888 | 0.040 |
Why?
|
| United States | 2 | 2021 | 73039 | 0.040 |
Why?
|
| Emergencies | 1 | 2003 | 1221 | 0.030 |
Why?
|
| Plasma | 1 | 2000 | 585 | 0.030 |
Why?
|
| Health Surveys | 2 | 2004 | 4057 | 0.030 |
Why?
|
| Anemia, Myelophthisic | 1 | 1976 | 6 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11095 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 682 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6316 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11879 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2021 | 1599 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1995 | 97 | 0.030 |
Why?
|
| Solutions | 2 | 1996 | 409 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2002 | 10399 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 525 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 1026 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4206 | 0.030 |
Why?
|
| Spleen | 1 | 1981 | 2295 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10474 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1995 | 338 | 0.030 |
Why?
|
| Risk Factors | 3 | 2006 | 74944 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2020 | 2089 | 0.030 |
Why?
|
| Disease Management | 1 | 2024 | 2536 | 0.030 |
Why?
|
| Ion Transport | 1 | 1995 | 322 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3728 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4427 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 1930 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2024 | 2346 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1886 | 0.030 |
Why?
|
| Sex Factors | 1 | 2006 | 10632 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 2560 | 0.030 |
Why?
|
| Buffers | 1 | 1992 | 143 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1995 | 633 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 1976 | 691 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2001 | 2025 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1976 | 718 | 0.020 |
Why?
|
| Viscosity | 1 | 1992 | 334 | 0.020 |
Why?
|
| Comorbidity | 1 | 2006 | 10590 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3109 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1992 | 657 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9384 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1992 | 252 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 1992 | 265 | 0.020 |
Why?
|
| Pregnancy | 2 | 2003 | 30256 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7608 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1990 | 112 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8741 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1981 | 5505 | 0.020 |
Why?
|
| Recurrence | 1 | 2002 | 8509 | 0.020 |
Why?
|
| Insulin | 1 | 2024 | 6607 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3055 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 6082 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 1976 | 2414 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2018 | 2381 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5536 | 0.020 |
Why?
|
| Protein Binding | 1 | 2000 | 9343 | 0.020 |
Why?
|
| Lung | 1 | 2005 | 10099 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 9263 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2020 | 5622 | 0.020 |
Why?
|
| Asthma | 1 | 2005 | 6291 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1976 | 2935 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 65371 | 0.020 |
Why?
|
| Adolescent | 3 | 2018 | 89169 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 13671 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 10873 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 20227 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24315 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 42669 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21538 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11878 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 30010 | 0.010 |
Why?
|
| Glycodeoxycholic Acid | 1 | 1996 | 23 | 0.010 |
Why?
|
| Taurodeoxycholic Acid | 1 | 1996 | 13 | 0.010 |
Why?
|
| Calorimetry | 1 | 1996 | 132 | 0.010 |
Why?
|
| Taurochenodeoxycholic Acid | 1 | 1996 | 35 | 0.010 |
Why?
|
| Demography | 1 | 2001 | 1641 | 0.010 |
Why?
|
| Micelles | 1 | 1996 | 191 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1996 | 489 | 0.010 |
Why?
|
| Permeability | 1 | 1996 | 725 | 0.010 |
Why?
|
| Urea | 1 | 1996 | 448 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 2173 | 0.010 |
Why?
|
| Heme | 1 | 1976 | 316 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1990 | 5446 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 60066 | 0.010 |
Why?
|
| Microvilli | 1 | 1990 | 235 | 0.010 |
Why?
|
| Detergents | 1 | 1990 | 235 | 0.010 |
Why?
|
| Light | 1 | 1996 | 1355 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 525 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1990 | 1647 | 0.000 |
Why?
|
| Iron | 1 | 1976 | 1813 | 0.000 |
Why?
|
| DNA | 1 | 1981 | 7214 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1990 | 2474 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 59629 | 0.000 |
Why?
|
| Child | 1 | 2001 | 80917 | 0.000 |
Why?
|
Concepts
(314)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_